America’s Overspend: How the Pharmaceutical Patent Problem is Fueling High Drug Prices

25 Oct 2017
View Resource

The American health system is poised to incur $55 billion in excess costs from pharmaceutical companies’ strategies to delay competition on three drugs

Partner with us now to build
a more just and equitable
medicine system for all.